July 17 (Reuters) - Immutep Ltd (IMM) :
- IMMUTEP LTD -RECEIVES REGULATORY CLEARANCE FOR PHASE I STUDY OF FIRST-IN-CLASS LAG-3 AGONIST ANTIBODY DESIGNED TO TREAT AUTOIMMUNE DISEASES
- IMMUTEP LTD -STUDY EXPECTED TO ENROL FIRST PARTICIPANTS DURING Q3 CY2024
July 17 (Reuters) - Immutep Ltd (IMM) : IMMUTEP LTD -RECEIVES...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
-0.010(3.51%) |
Mkt cap ! $400.0M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.3¢ | 27.0¢ | $1.034M | 3.758M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 98156 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 85523 | 9 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |